Emerging Treatment Options for the Management of Metastatic Colorectal Cancer
Education is needed to help clinicians understand which biomarkers and other criteria should be considered during treatment decision-making in this rapidly evolving landscape. Getting the right treatment to the right patients and utilizing optimal treatment strategies can maximize benefits while minimizing harms, giving patients with mCRC the best quality and quantity of life possible.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Role of Biosimilars in the Oncology Ecosystem
While biosimilars and generics are not the same, biosimilars are very likely to adopt the same role in the market over the next decade; however, their safety, efficacy, and general role in the clinical setting remains unclear.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Implementing Clinical Trials in the Community Setting
Many community practices do not have the necessary resources and expertise to offer clinical trials to patients, which limits access in remote areas.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Multidisciplinary Management of Advanced Kidney Cancer
Clinicians will benefit from a discussion of various patient cases using high-level clinical evidence that take into account patient risk, surgical resectability, cancer stage, and the emerging data from approved therapies to individualize the treatment and maximize outcomes.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia
The management of histologic transformation of CLL to aggressive lymphomas remains an unmet clinical need since the standard of care is not established. Treatment selection for patients with CLL without del(17p)/TP53 mutation should be individualized based patient’s age, performance status, comorbid conditions, as well as the agent’s toxicity profile. Oncologists and hematologists need to understand the unique challenges associated with the management of histologic transformation of CLL.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Trimodal Therapy Approaches for Localized Rectal Cancer
Trimodal therapy approaches for localized rectal cancer continue to evolve as new data helps define the approaches that will best improve outcomes while reducing adverse effects, as well as which patients will benefit from these treatment methods.  Clinicians would benefit from education on relevant clinical trial results and how they may be best applied to clinical practice.
Category
  • Rectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Rectal Cancer
The determination of an optimal treatment plan for patients with rectal cancer is a complex process that is reliant on balancing the potential risks and benefits of each treatment option based on an individual patient’s characteristics. Clinicians must be educated about on emerging approaches to personalized treatment for patients with rectal cancer so that the most appropriate treatment options can be offered to each patient.
Category
  • Rectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Locoregional Management of Early-Stage Breast Cancer
Locoregional management strategies have considerably evolved.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Improving Efficiency and the Patient Experience in the Ambulatory Setting
Feedback should be obtained from nursing staff regarding strategies and ideas for improving efficiency and experience for patients with cancer in the ambulatory setting.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Evolution of Immunotherapy and Management of Complex Toxicities
Nurses play a critical role in the recognition and management of immune-related adverse events (irAEs). Education and training are needed to manage the needs of the growing patient population treated with these agents, particularly as our understanding of best practices for addressing complex toxicities evolves. The NCCN Guidelines provide helpful recommendations for assessing and managing irAEs in order to support optimal management of potentially life-threatening adverse events.
Category
  • Management of Immunotherapy-Related Toxicities
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages